Clinical Trial Update: A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode [Phase 3]

View source ↗

Summary

A Phase 3 multicenter study evaluated extended administration of aripiprazole in combination with a mood stabilizer for Bipolar I Disorder patients experiencing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Bipolar I Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-02-12